INSIGHTS ON DRUG DEVELOPMENT
-
![Antibodies GettyImages-1441786721]( "Solid State Hydrogen Deuterium Exchange To Study Antibody Drug Conjugate Stability")
Solid State Hydrogen Deuterium Exchange To Study Antibody Drug Conjugate StabilityDiscover how this solid-state HDX-MS is being used to revolutionize the prediction of stability for IgG-based antibody drug conjugates and enhance ADC development processes.
-
![GettyImages-959950866-Nasal Spray Bottles]( "In Vivo Testing Of Nasal Dosage Forms")
In Vivo Testing Of Nasal Dosage FormsInnovative nasal drug delivery strategies can unlock faster, patient-friendly therapeutic solutions by combining smart formulation, advanced testing platforms, and rigorous preclinical evaluation.
-
![GettyImages-1185624320-scientist-lab-smiling]( "Selecting A CDMO For Custom Activated PEGs")
Selecting A CDMO For Custom Activated PEGsCustom-activated PEGs require thoughtful planning and precise analytical control. Discover key considerations for selecting a partner capable of supporting scalable, compliant PEGylation.
-
![resDNASEQ Cinematic]( "An All-In-One Solution For Residual DNA Quantitation")
An All-In-One Solution For Residual DNA QuantitationExplore an all-in-one solution for residual DNA quantitation with a 3D lab tour with virtual demos, videos, and interactive instrument guides to experience the full workflow.
-
Functional Characterization Of 3D Assembled Neurospheres4/4/2025
Neural organoids and 3D spheroids offer advanced platforms for brain research and drug discovery. Discover how creating 3D neurospheres from iPSC-derived neurons and astrocytes aids in compound profiling and toxicity testing.
-
Spray Dried Biologics For Injectable Dosage Forms5/15/2026
Spray drying enables scalable production of stable, high‑concentration biologics as sterile powders, improving delivery, reducing costs, and overcoming limitations of traditional freeze‑drying methods.
-
How CRISPR And LNP Accelerate Therapeutic Innovation Through Analytics9/2/2025
CRISPR gene editing and lipid nanoparticle delivery are revolutionizing precision medicine. Discover how optimized LNP systems and advanced analytics accelerate therapeutic development.
-
Streamline Drug Development With A Lab Informatics Platform8/13/2025
Learn how a tiered approach to ADME-Tox studies can help researchers navigate early-stage preclinical research and mitigate the risk of costly failures in drug development.
-
Understanding Adeno-Associated Virus Vector Impurities11/13/2025
AAV vectors hold promise for gene therapy, but removing product-related impurities remains a challenge. Learn how cell line development and process optimization are advancing rAAV production.
DRUG DEVELOPMENT SOLUTIONS
-
![Duo Digital Dispenser™]( "Picoliter Dispensing Redefined, Now For Single Cells Too")
Accelerate single-cell and low-volume workflows with high precision, fast setup, and surfactant-free dispensing that delivers reproducible results and flexible performance across cell types and reagents.
-
![White Tablets-GettyImages-172969989]( "Enhanced Opacity With Ideal Particle Properties")
Titanium dioxide is extensively used in solid dosage forms as an opacifier and colorant. Due to regulatory developments and restrictions by authorities, formulators are increasingly interested in titanium dioxide-free solutions for both dietary supplements and medicinal products. Uniform colored and white coatings applied to tablets not only have an aesthetic function but also improve patient compliance.
-
![Rigaku Miniflex X-Ray Defractor]( "Used Rigaku Miniflex X-Ray Diffractometer")
Rigaku Miniflex X-Ray defractor, (6) sample capacity, water cooled, 115 volts, serial# TD01111.
-
![GettyImages-1327977866-cell-culture-sample-laboratory]( "Powering Production Of Viral Vector-Based Therapies")
Gene therapies hold immense potential to provide long-lasting treatments for a wide range of diseases. At Cytiva, we offer GMP-compliant, end-to-end manufacturing solutions designed to support the development and commercialization of advanced medicines across multiple modalities – including AAV, adenovirus (AV), lentivirus (LV), plasmid DNA (pDNA) and exosomes. Our dependable suite of technologies and expertise ensures scalability, quality, and regulatory confidence at every stage of your journey.
-
![GettyImages-1400218353-eco_environment_city_green_sustainable]( "Small Is Powerful, Small Is Green")
As the pharmaceutical industry innovates and evolves, learn more about how Nanoform can play a critical role in empowering your company's journey to net zero.
